Martijn J. Van Hemert
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.
Journal: Biochemical pharmacology
Published: January 28, 2026
A yellow fever 17D and Usutu virus chimera with rationally designed mutations in the envelope protein is lethal in an Ifnar-/- mouse model.
Journal: Virology journal
Published: December 16, 2025
Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 Mpro and Cathepsin.
Journal: Journal of medicinal chemistry
Published: May 26, 2025
Structural insights into MERS and SARS coronavirus membrane proteins.
Journal: Communications biology
Published: April 07, 2025
Attenuating Mutations in Usutu Virus: Towards Understanding Orthoflavivirus Virulence Determinants and Live Attenuated Vaccine Design.
Journal: Vaccines
Published: March 14, 2025
Vault RNAs aid RNA virus infection by facilitating cytoplasmic localization of hnRNP C and ELAVL1.
Journal: Cell reports
Published: September 27, 2024
A coronavirus assembly inhibitor that targets the viral membrane protein.
Journal: Nature
Published: April 06, 2024
Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses.
Journal: ACS central science
Published: March 28, 2024
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.
Journal: Nature
Published: February 21, 2024
Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome.
Journal: Nucleic acid therapeutics
Published: October 02, 2023
SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.
Journal: Clinical & translational immunology
Published: September 08, 2023
Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients.
Journal: Kidney international reports
Published: June 16, 2023
Last Updated: 09/26/2026